Common Psychological Problems in Older Adults and Intervention Strategies: A Biopsychosocial Systems Analysis

Common Psychological Problems in Older Adults and Intervention Strategies: A Biopsychosocial Systems Analysis

Best for: Geriatricians and psychiatrists, general practitioners and community nurses, clinical psychologists and social workers, managers of long-term care and integrated eldercare services, and researchers or trainers working on late-life mental health policy and family caregiver education. Primary keywords: late-life mental health; geriatric depression; anxiety disorders; behavioural and psychological symptoms of dementia; psychological intervention; biopsychosocial model

Short Answer

The main psychological problems in older adults form five spectra: late-life depression, anxiety disorders, behavioural and psychological symptoms of dementia (BPSD), sleep disturbance, and loneliness with social isolation. Prevalence shows marked sex and urban-rural differences. Epidemiological data indicate that depression prevalence rises by about 9.2 percent for every additional 20 years of age, anxiety-depression comorbidity reaches 30 to 50 percent, and more than 90 percent of people with dementia develop neuropsychiatric symptoms during the illness; insomnia risk is 3.677 times higher in women than men (95 percent CI 2.124 to 6.365). Mechanistically, neuroinflammation with elevated IL-6 and CRP, high neuroticism, and social isolation form a key risk chain, while cognitive reserve, psychological resilience, and intergenerational support are protective; the odds ratio linking social support to depressive symptoms ranges from 1.16 to 1.41, and high support protects against multimorbidity (OR 0.67, 95 percent CI 0.57 to 0.76). For assessment, GDS-15 and GAI perform well in older Chinese populations, and MoCA detects mild cognitive impairment far more sensitively than MMSE (0.80 to 0.90 versus 0.60 to 0.75), though cognitive impairment systematically weakens self-report validity. For treatment, group cognitive behavioural therapy adapted for older adults and reminiscence therapy combined with memory specificity training both outperform usual care. The most actionable pathway today is embedding mental health screening in the annual health check and building a multidisciplinary stepped-care system.

1. Introduction: The Mental Health Challenge of Population Ageing and the Research Framework

According to United Nations data, the global population aged 60 and above will grow from about 600 million to 2 billion between 2000 and 2050, more than tripling, with most growth in less developed countries. China has the largest older population in the world: by the end of 2020, 264.02 million people were aged 60 or above, 18.7 percent of the total population, and that figure is expected to exceed 400 million around 2035. Health needs are shifting from treating somatic disease alone toward comprehensive management covering psychological and social function, yet late-life mental health has not received attention proportionate to its epidemiological burden.

Step 1: Identify the gap between service supply and policy goals

Three gaps persist despite mental health being embedded in national health strategy and dedicated guidance on building services for older adults. First, trained professionals are scarce: the number of psychiatrists and psychotherapists is far below that of developed countries, specialists trained in geriatric psychology are especially rare, and community services are staffed mainly by general practitioners or nurses working concurrently, producing low recognition and high misdiagnosis rates. Second, social misattribution is widespread: shaped by traditional culture, many older adults and their families treat depression and anxiety as a normal part of ageing, delaying help-seeking, while ageism in the health system leads some clinicians to attribute psychological complaints to somatic disease or cognitive decline. Third, services are fragmented across psychiatric hospitals, geriatric departments of general hospitals, community health centres, and care facilities, without effective referral and collaboration mechanisms.

Step 2: Adopt the biopsychosocial framework

The traditional biomedical model reduces disease to biological abnormality, cannot explain distress without clear pathological change, and struggles with the psychosocial needs of patients with chronic illness. The biopsychosocial model proposed by Engel in 1977 holds that health and disease result from interaction among biological, psychological, and social dimensions. Its advantages in late-life mental health are distinctive: it explains why some older adults develop severe depression while others remain resilient despite similar biological ageing; it redirects intervention from symptom treatment toward whole-person care, requiring cognitive behavioural therapy, life review therapy, social support building, and physical activity alongside medication; and it aligns with active ageing by treating mental health promotion as a proactive process across the whole of later life.

Step 3: State the core research questions

This study addresses three questions: what are the epidemiological features and risk-factor network of common psychological problems in older adults; how can systematic and actionable assessment and intervention strategies be built on the biopsychosocial model; and what does the evidence say about intervention effectiveness, and where are the boundaries of applicability in the Chinese cultural context.

2. Epidemiology and Clinical Presentation

Step 1: Summarise prevalence and distinctive features of late-life depression

A four-province survey in China covering 2001 to 2005 reported an affective disorder prevalence of 6.1 percent, with marked sex and urban-rural differences in older adults: women higher than men, and rural residents at significantly higher risk of major depressive disorder than urban residents. Clinical presentation differs from younger adults. Somatisation is a core feature, with patients presenting chronic pain, digestive complaints, chest tightness, or palpitations rather than directly expressing low mood, which substantially lowers recognition. Cognitive impairment manifests as inattention, memory decline, and reduced executive function, and some patients show a pseudodementia state that is difficult to distinguish from mild cognitive impairment. High anxiety-depression comorbidity is a common pattern in which anxiety symptoms may mask the core depressive experience. Suicide risk must not be overlooked: the suicide rate among depressed people is about 20 times that of the general population, and roughly 10 to 15 percent of patients engage in suicidal behaviour.

Step 2: Characterise age-specific features of anxiety disorders

The same four-province survey placed anxiety disorder prevalence at 5.6 percent. Anxiety shows substantial comorbidity with cardiovascular disease, respiratory disease, and diabetes, possibly mediated by shared pathways such as hypothalamic-pituitary-adrenal axis dysregulation and inflammatory mechanisms. Compared with younger adults, older adults worry more about health, financial security, falls, and becoming a burden rather than the free-floating worry of generalised anxiety, and they present somatically with palpitations, dizziness, breathlessness, and muscle tension that overlap with physical illness and complicate diagnosis.

Step 3: Identify behavioural and psychological symptoms of dementia

More than 90 percent of people with dementia develop neuropsychiatric symptoms during the illness. BPSD includes affective symptoms such as depression and anxiety, psychotic symptoms such as delusions and hallucinations, behavioural symptoms such as aggression, agitation, wandering, and sleep disturbance, and autonomic symptoms. Frequency and severity rise as cognition declines and may predict conversion from mild cognitive impairment to dementia. Mechanistically, cholinergic, dopaminergic, and serotonergic dysfunction interacts with environmental stimulation. Burden on caregivers is especially pronounced: behavioural symptoms more than cognitive symptoms drive caregiver psychological distress and physical decline.

Step 4: Position sleep disturbance and loneliness

Insomnia prevalence shows a marked sex difference, with women 3.677 times more likely than men to report insomnia symptoms (95 percent CI 2.124 to 6.365). Sleep and psychological problems are bidirectionally related: depression and anxiety are important risk factors for insomnia, and chronic insomnia increases the risk of both. Late-life insomnia more often presents as early awakening and sleep fragmentation linked to age-related reductions in slow-wave sleep and sleep efficiency. Loneliness and social isolation are psychosocial problems specific to later life: social isolation affects mental health by reducing social support and access to resources, whereas loneliness acts through stress system activation and inflammatory pathways.

Step 5: Consolidate prevalence and clinical features

3. Risk and Protective Factors and Their Interaction

Step 1: Trace neuroinflammation as an upstream driver

The neurobiological basis of late-life depression and anxiety involves coordinated dysregulation across systems. At the neurotransmitter level, ageing reduces synthesis and receptor sensitivity of serotonin, noradrenaline, and dopamine, a change especially pronounced in depressed older adults. Recent work, however, focuses on neuroinflammation as the upstream mechanism: chronic stress activates the hypothalamic-pituitary-adrenal axis, sustaining elevated glucocorticoid levels and triggering peripheral and central immune activation, with elevated proinflammatory cytokines such as IL-6 and CRP as core markers. A meta-analysis confirmed significantly higher IL-6 in depressed patients than in healthy controls, an association consistent transdiagnostically across affective disorders. Neuroinflammation impairs neuroplasticity by suppressing brain-derived neurotrophic factor expression, damaging hippocampal neurogenesis, and disrupting functional connectivity between prefrontal cortex and amygdala; magnetic resonance studies in untreated late-life generalised anxiety disorder have observed microstructural changes in dorsomedial, ventromedial, and ventrolateral prefrontal cortex. About one quarter of depressed patients show a pronounced neuroinflammatory profile, and these patients tend to have poorer prognosis and weaker response to standard antidepressants.

Step 2: Analyse personality and resilience as moderators

Neuroticism, the tendency to experience negative emotions, is one of the strongest psychological predictors of late-life depression and anxiety. Highly neurotic individuals are more sensitive to stressful life events and tend toward negative attributional styles, amplifying stress effects; research shows the covariation between neuroticism and depressive or anxious symptoms is partly mediated by lifestyle factors including physical activity, social participation, and sleep quality. Psychological resilience is a major protective resource. Among widowed older adults, resilience significantly moderates the effect of negative life events on depressive symptoms: even after spousal loss, the increase in depressive symptoms is markedly smaller in highly resilient individuals. Mechanisms may include stronger cognitive reappraisal, active help-seeking, and sustained meaning in life. Meaning in life, a core component of resilience, buffers the impact of ageing-related losses by providing goal direction and existential value. Resilience is not fixed; it can be cultivated through life review therapy and mindfulness training.

Step 3: Examine the two-sided nature of social support and cultural variation

In the Chinese cultural context, family intergenerational support is the core of the social support network. Emotional support from adult children significantly reduces loneliness and depression risk, with the strongest protective effect among empty-nest older adults. When intergenerational support takes the form of financial dependence or over-care, however, it can weaken autonomy and self-efficacy and increase distress. Research on Chinese community-dwelling older adults found that social ties with friends protected against depressive symptoms in some respects more strongly than family ties, particularly in urban settings, suggesting that peer networks offering egalitarian interaction and shared interests may better meet socioemotional needs. Social isolation is among the most dangerous independent risk factors; left-behind older adults face double deprivation of emotional exchange and emergency support, and among those with somatic multimorbidity, weak support networks correlate strongly with elevated suicide risk.

Step 4: Confirm that protective factors are modifiable

Cognitive reserve is the brain's capacity to maintain function despite neuropathology, built on higher education, occupational complexity, and rich leisure participation; cognitive resilience is related but distinct, emphasising dynamic adaptation and compensation. In depressed older adults, higher cognitive reserve buffers depression-related damage to executive function and memory. Physical activity is another powerful protective factor: regular aerobic exercise promotes mental health by increasing hippocampal volume and neurotrophic factor expression, lowering systemic inflammation, improving sleep quality, and providing social interaction. Conditional process analysis in Chinese older adults showed sleep quality mediates the link between negative life events and depression, with income moderating the first half of that pathway, which suggests exercise may interrupt the chain indirectly by improving sleep.

Step 5: Build the interaction model and identify intervention targets

4. Assessment Tool Selection and Diagnostic Challenges

Step 1: Establish assessment principles

Assessment of late-life psychological problems must be multidimensional and draw on multiple informants. Because older adults frequently have somatic illness, cognitive decline, and polypharmacy, assessment needs to integrate biological, psychological, social, and functional dimensions to avoid misjudgement from a single instrument. Tool choice must consider validity evidence in older populations, especially performance in subgroups defined by education, culture, and cognitive status.

Step 2: Check validity evidence for commonly used tools

The Chinese version of the 15-item Geriatric Depression Scale has been widely validated in older Chinese adults, with internal consistency Cronbach alpha typically between 0.75 and 0.89; its yes-or-no format lowers cognitive load, sensitivity is about 0.85 to 0.90, specificity about 0.75 to 0.85, and the optimal cut-off is usually 5 to 6. In older adults with primary school education or less, however, sensitivity may fall to 0.70 to 0.75, requiring supplementary methods. The Chinese version of the Geriatric Anxiety Inventory has a Cronbach alpha of 0.88 to 0.92 and good test-retest reliability (r = 0.85 to 0.90); its items deliberately exclude somatic symptoms such as palpitations and sweating, improving discriminant validity in patients with physical comorbidity, although use in mild cognitive impairment requires caution. For cognition, MoCA detects mild cognitive impairment far more sensitively than MMSE (0.80 to 0.90 versus 0.60 to 0.75) but takes longer and is highly education-sensitive; language and cultural factors significantly affect validity in Chinese users, so cultural adaptation and local norms are needed.

Step 3: Recognise three diagnostic challenges

Step 4: Correct for cultural effects on scale performance

Instruments developed in Western settings face adaptation challenges in older Chinese populations. Older Chinese adults more often describe emotional distress in somatic language, for example reporting a heavy feeling in the chest or generalised discomfort rather than sadness or worry, which can reduce the sensitivity of GDS and GAI. The GDS item asking whether life feels empty, for instance, may be read as an objective description of circumstances rather than an emotional symptom. Traditional stigma around mental illness may also lead older adults to understate or deny symptoms, further limiting self-report validity. Clinical use should interpret scores within a culturally sensitive interview, and where necessary adopt locally developed instruments or culturally adapt Western tools.

Step 5: Implement the screen-diagnose-function three-step approach

Step one uses GDS-15 or GAI for rapid screening combined with informant reports to raise sensitivity. Step two applies structured clinical interviews such as SCID or MINI to those screening positive in order to establish diagnosis. Step three evaluates the impact of the problem on activities of daily living, social function, and quality of life to inform the intervention plan. For those with cognitive impairment, dedicated tools such as the Cornell Scale for Depression in Dementia should be preferred, with longer assessment time and streamlined procedures. For those with physical comorbidity, attention to temporal association and emotional colouring helps avoid misclassifying somatic symptoms as psychological problems.

5. Integrated Intervention Strategies and Service Systems

Step 1: Adapt cognitive behavioural therapy to older adults

Cognitive behavioural therapy faces challenges in older adults from cognitive decline, slower information processing, and reduced memory capacity, requiring systematic adaptation: simplify cognitive restructuring by converting complex thought records into visual tools; extend sessions to 60 to 90 minutes with added repetition; and introduce memory aids such as written summaries, voice reminders, and family-assisted homework. A quasi-experimental study in late-life affective disorders found that 62.3 percent of patients receiving transdiagnostic group cognitive behavioural intervention achieved at least a 50 percent reduction in Hamilton Depression Rating Scale scores and automatic negative thoughts fell by 35.7 percent, both significantly better than the 48.1 percent and 27.4 percent in conventional therapy, with dropout about 15 percentage points lower. Mechanistically, cognitive simplification reduces executive demands, memory aids compensate for episodic memory deficits, and the group format adds social support.

Step 2: Standardise combined pharmacotherapy and psychotherapy

Selective serotonin reuptake inhibitors are first-line for late-life depression and anxiety, with adverse effects including drowsiness, nausea, dry mouth, sweating, anxiety, anorexia, and dyspepsia. Clinicians must note that 25 to 30 percent of older patients with depression actually have bipolar disorder, in which these agents may trigger mania and mood stabilisers such as lithium are required instead. The key variable in combination therapy is sequencing: starting medication first and reaching steady-state concentrations over 2 to 4 weeks before introducing psychotherapy reduces early treatment anxiety and improves adherence. For polypharmacy, older patients often have cardiovascular disease and diabetes, so interactions demand vigilance; combined use with warfarin, for example, markedly increases bleeding risk and requires close monitoring of the international normalised ratio. The Beers criteria indicate that about 28 percent of drug-related problems in hospitalised older adults stem from polypharmacy, supporting a start-low, go-slow approach with periodic medication review.

Step 3: Evaluate the specific efficacy of reminiscence and life review therapy

For depressive symptoms in older adults with mild cognitive impairment, reminiscence therapy combined with memory specificity training outperforms usual care. A multicentre, single-blind, three-arm parallel randomised controlled trial protocol enrolled 78 older participants; the intervention group received eight weeks of the combined programme and improved autobiographical memory test scores by 42.3 percent with a 38.6 percent reduction in Geriatric Depression Scale scores. The causal chain is interpretable: memory specificity training activates hippocampal and prefrontal neuroplasticity to strengthen episodic retrieval, while reminiscence works through emotion regulation, reactivating reward circuitry by revisiting positive events, and through meaning construction, integrating self-identity through life review. Compared with standard cognitive behavioural therapy, the combined programme has lower executive demands, exploits relatively preserved autobiographical memory, and requires a shorter therapist training period, making it suitable for community scale-up.

Step 4: Address access and adherence gaps in digital interventions

Telehealth and mobile health applications show potential to improve access, with a systematic review of telehealth indicating that remote consultation raises treatment adherence by about 20 to 30 percent, especially for patients with limited mobility or in remote areas. Effect is moderated by modality: video consultation builds therapeutic alliance better than telephone, and both trail face-to-face care. Barriers include limited digital literacy, difficulty obtaining devices, and privacy concerns. Urban-rural stratification shows completion rates of about 65 to 75 percent among urban older adults versus 30 to 45 percent in rural areas, a gap driven mainly by network coverage, device penetration, and digital literacy training. Digital intervention should therefore complement rather than replace stepped care, paired with community digital literacy training and technical support in rural areas.

Step 5: Build stepped care and implement integrated eldercare

Local implementation of integrated medical and eldercare models faces multiple barriers. All four prevailing models, namely community hospitals supporting care homes, public hospital outreach teams, care homes operating their own clinics, and hospitals directly running care homes, under-serve mental health. Critical resource gaps include 15 to 20 psychotherapists per 100,000 older adults in developed countries versus fewer than 3 in China, and social care beds at 5 to 7 percent of the older population in developed countries versus about 2 percent in China, with most facilities lacking staff trained in long-term care. The causal chain runs from fragmented policy and difficult cross-departmental coordination, to reimbursement systems that exclude psychotherapy, to social misattribution that suppresses help-seeking. Priority measures include establishing mental health service stations in community health centres staffed with at least one full-time psychotherapist and two social workers, and building teleconsultation links with higher-level psychiatric hospitals to close the loop from screening to intervention, referral, and follow-up.

6. Discussion: Effect Heterogeneity, Implementation Barriers, and Research Limits

Step 1: Explain cross-cultural heterogeneity in intervention effects

Systematic reviews place the average effect of cognitive behavioural therapy on psychological outcomes in older adults at roughly 0.45 to 0.65, but trials from high-income Western countries generally exceed those from low- and middle-income settings. Three explanations apply. First, cultural fit is a key variable: the cognitive restructuring emphasised in the original protocol may work less well when older adults construe the link between thought and emotion differently. Second, structural differences in health systems produce uneven intervention intensity; simplified group delivery by non-specialists is feasible in low-resource settings, but dose correlates with effect. Third, baseline severity creates a stratification effect: among community older adults with mild symptoms the difference from usual care is small (standardised mean difference 0.28, 95 percent CI 0.12 to 0.44), rising to 0.61 (95 percent CI 0.42 to 0.80) in moderate to severe cases. Heterogeneity in reminiscence and life review therapy is driven more by cultural values: in collectivist cultures, interventions emphasising family bonds and intergenerational continuity outperform standardised protocols from individualist settings, though this gain has not been consistently replicated in all ethnic groups.

Step 2: Enumerate implementation barriers

On adherence, dropout from 12-week interventions ranges from 15 to 35 percent, driven by stigma, which can reduce active help-seeking by 40 to 60 percent in rural areas, by misaligned expectations of benefit, and by access barriers from physical comorbidity; 68 percent of urban older adults complete eight or more sessions versus 41 percent in rural areas, and adherence among those with mild cognitive impairment is about 25 percent lower than in cognitively normal peers. On workforce, low- and middle-income countries have only 0.5 to 2 mental health professionals per 100,000 older adults, far below the World Health Organization benchmark of 15, and although task-shifting is feasible, Japanese research shows non-specialists trained for 40 hours deliver effects about 0.2 standard deviations smaller than professionals. On resources, rural mental health coverage is less than one third of urban coverage, out-of-pocket psychotherapy consumes 15 to 25 percent of monthly rural income for older adults, and mental health services remain disconnected from chronic disease management and eldercare.

Step 3: Examine methodological limitations

Sample representativeness shows systematic bias: the median share of rural participants in published randomised trials is only 18 percent, while rural older adults make up 56 percent of China's older population; people with severe cognitive impairment are excluded from almost all psychological intervention trials, leaving the non-pharmacological evidence base for BPSD thin; and most studies use convenience sampling or voluntary participation, skewing samples toward those with higher education, better health literacy, and stronger support, which overestimates real-world effect. Missing long-term follow-up is the core bottleneck for assessing durability: a meta-analysis of five studies found that in trials following patients beyond 24 months, cognitive behavioural therapy prevented depressive relapse better (hazard ratio 0.68, 95 percent CI 0.51 to 0.89) than in shorter-follow-up studies (0.82, 95 percent CI 0.67 to 1.01), yet such trials are very few and generally small. Heterogeneous control conditions, divergent outcome measures, and inadequate reporting of treatment fidelity, with only about 40 percent of studies reporting therapist training and supervision data, further limit comparability.

Step 4: Define the boundaries of applicability

Cognitive behavioural therapy and reminiscence therapy work best for community-dwelling older adults with mild to moderate depression or anxiety and normal cognition. For rural, low-education, severely cognitively impaired, or highly multimorbid groups, current evidence does not support generalised application. Culturally adapted interventions show promise in non-Western settings, but the magnitude and stability of the added benefit still require trials with larger samples and longer follow-up.

7. Conclusion: Clinical Practice, Policy Recommendations, and Research Directions

Step 1: Set out the clinical pathway

Embedding mental health screening in the national basic public health annual examination is the most cost-effective entry point. Brief tools should be inserted into the existing framework, using GDS-15 for depression, GAD-7 for anxiety, and a single question on loneliness and social isolation. Those screening positive enter a two-step referral: mild cases receive initial psychoeducation and non-pharmacological intervention from the community general practitioner, while moderate to severe cases are referred to the psychiatric or geriatric mental health clinic of a higher-level hospital. A multidisciplinary team comprising geriatricians, psychiatrists, clinical psychologists, community nurses, rehabilitation therapists, and social workers should follow a closed assessment-intervention-follow-up loop. For patients with cognitive impairment, non-pharmacological BPSD intervention should come first, with antipsychotics used cautiously only when behavioural symptoms severely threaten safety or quality of life.

Step 2: Propose public health policy measures

A four-level system covering prevention, early identification, treatment, and rehabilitation is recommended. Primary prevention targets all older adults through community health education and promotion of active lifestyles and social participation. Secondary prevention focuses on high-risk groups such as empty-nest older adults, bereaved spouses, and people with chronic disease, with regular assessment and follow-up by community staff. Tertiary intervention provides evidence-based psychotherapy and standardised pharmacotherapy for diagnosed conditions. Quaternary rehabilitation emphasises functional recovery and social reintegration. For urban-rural differentiation, urban communities can build mental health stations with dedicated psychologists in community health centres, while rural areas should train village doctors in basic psychological assessment and crisis intervention, using village clinics as service points and mobilising senior associations and neighbour mutual-aid networks. On financial protection, psychotherapy should be included in basic medical insurance reimbursement, with targeted subsidies for low-income older adults.

Step 3: Clarify priorities for family and community care

Family caregivers carry heavy psychological pressure and care burden, and depression and anxiety prevalence among dementia caregivers is substantially higher than in the general population. Caregivers should receive systematic training covering disease knowledge, communication skills, behaviour management, and self-care, alongside respite services. Communities should act as the hub for late-life mental health services by establishing professional counselling venues and hotlines, organising interest groups, senior colleges, and volunteering, building neighbour mutual-aid mechanisms, and regularly visiting empty-nest, bereaved, and solo-living older adults to assess psychological state and living needs.

Step 4: Plan future research directions

Future work should focus on five areas: multicentre randomised trials targeting rural and cognitively impaired subgroups with stratified randomisation to balance urban and rural enrolment; follow-up mechanisms of at least 24 months incorporating competing-risk analysis for death and attrition; development and validation of culturally sensitive assessment tools and interventions, such as integrated reminiscence therapy aligned with the family-centred values of older Chinese adults; cost-effectiveness evaluation of task-shifting in low-resource communities, including training costs, delivery costs, and quality-adjusted life-year ratios; and systematic use of implementation science frameworks to assess reach, adoption, fidelity, and sustainability, closing the evidence-to-practice gap.

Step 5: Build evidence synthesis capacity into research infrastructure

That agenda spans epidemiology, neuroinflammatory mechanisms, psychometrics, implementation science, and health economics, and the required evidence is scattered across Chinese and international databases, clinical guidelines, and policy documents. The cost of cross-database retrieval, certainty grading, and harmonising definitions usually exceeds what a single group can sustain. QSevidence applies AI guideline retrieval, literature-based evidence work, and structured evidence generation to help researchers compile original recommendation entries from late-life mental health guidelines and consensus statements, annotate publication years and target populations, produce reviewable evidence tables under a consistent framework, and preserve the complete retrieval path with source links for professional review. This gives policy proposals such as embedding mental health screening in the annual examination a traceable evidentiary basis, and gives comparative studies of cross-cultural intervention effects a reproducible methodological foundation.

References

1. World Health Organization. World report on ageing and health. Geneva: WHO; 2015.
2. National Bureau of Statistics of China. Communique of the Seventh National Population Census. Beijing: NBS; 2021.
3. Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196(4286):129-136.
4. Rowe JW, Kahn RL. Successful aging. Gerontologist. 1997;37(4):433-440.
5. Zhao Y, Hu Y, Smith JP, et al. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014;43(1):61-68.
6. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale. J Psychiatr Res. 1982;17(1):37-49.
7. Pachana NA, Byrne GJ, Siddle H, et al. Development and validation of the Geriatric Anxiety Inventory. Int Psychogeriatr. 2007;19(1):103-114.
8. Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-699.
9. Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell Scale for Depression in Dementia. Biol Psychiatry. 1988;23(3):271-284.
10. Bohlmeijer E, Smit F, Cuijpers P. Effects of reminiscence and life review on late-life depression: a meta-analysis. Int J Geriatr Psychiatry. 2003;18(12):1088-1094.
11. Cuijpers P, Karyotaki E, Pot AM, et al. Psychotherapy for depression in older adults: a meta-analysis. Am J Psychiatry. 2014;171(6):635-648.
12. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613.
13. Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-1097.
14. Steinman MA, Beizer JL, DuBeau CE, et al. How to use the American Geriatrics Society Beers Criteria. J Am Geriatr Soc. 2015;63(11):2227-2246.
15. World Health Organization. Integrated care for older people (ICOPE): guidance for person-centred assessment and pathways in primary care. Geneva: WHO; 2019.
16. QSevidence official website (qsevidence.com): AI guideline retrieval, literature evidence work, and structured evidence generation.

Medical Disclaimer

This article is based on published epidemiological surveys, randomised controlled trials, systematic reviews, and policy documents, and is intended for medical education, research methodology, and clinical study design reference only. It does not constitute any diagnostic, therapeutic, or psychological intervention recommendation. The prevalence figures, effect sizes, and psychometric indices discussed derive from existing literature and their applicability varies across populations; they must not be used to make individualised decisions about diagnosis, medication, or psychotherapy. Psychological problems in older adults are usually interwoven with somatic disease, cognitive impairment, and polypharmacy, so clinical assessment and intervention must be carried out by qualified geriatric, psychiatric, or clinical psychology professionals, with informed consent and ethics review, in accordance with individual circumstances and current guidelines.